Zach W. Hall
Corporate Officer/Principal bei NeuroVentures Capital LLC
Profil
Dr. Hall is the former President and CEO of EnVivo Pharmaceuticals, Inc. He was also the Former Vice Chancellor of the University of California, San Francisco; and Former Director of the National Institutes of Health and the National Institute of Neurological Disease and Stroke .
Zach Hall is a retired neuroscientist whose laboratory studied the molecular structure and development of the neuromuscular junction.
He received his Ph.D.
with Ed Kravitz at Harvard University in 1966.
Following two years of post-doctoral work in the Department of Biochemistry at Stanford, Hall returned to Harvard to join the new Department of Neurobiology as an Assistant Professor.
In 1976 he moved to UCSF where he started the Neuroscience Graduate Program.
From 1994-97 he was director of the National Institute of Neurological Disorders and Stroke before returning to UCSF as Executive Vice Chancellor, with responsibility for developing the campus at Mission Bay.
He then held a series of administrative positions, including the CEO of EnVivo Pharmaceuticals and later Associate Dean for Research at the Keck School of Medicine at the University of Southern California.
His last position was as the first president of the California Institute of Regenerative Medicine, a new state agency to fund stem cell research in California.
Hall was one of the founding editors of Neuron, and is the author and editor of a textbook, An Introduction to Molecular Neurobiology.
He has received a number of honors, including the Purkynje Medal from the Czech Academy of Sciences.
Hall, who now lives in Wilson, WY, currently serves as an advisor and board member for Target ALS, a privately-funded research project to develop therapies for ALS.
Aktive Positionen von Zach W. Hall
Unternehmen | Position | Beginn |
---|---|---|
NeuroVentures Capital LLC
NeuroVentures Capital LLC Investment ManagersFinance NeuroVentures Capital LLC (NeuroVenture Capital) is a venture capital firm founded in 1999 by Mark A. Cochran, Daniel J. O'Connell and Hans von Celsing. The firm is headquartered in Charlottesville, Virginia. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Zach W. Hall
Unternehmen | Position | Ende |
---|---|---|
Nitrase Therapeutics, Inc.
Nitrase Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nitrase Therapeutics, Inc. develops drugs against newly discovered nitration enzyme. The firm provides disease modifying drugs for multiple additional aging-dependent diseases, such as neurodegenerative disease, heart disease and cancer. The company was founded by Irene Griswold-Prenner and is headquartered in Jackson, WY. | Direktor/Vorstandsmitglied | - |
The University of California, San Francisco | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
NeuroVentures Capital LLC
NeuroVentures Capital LLC Investment ManagersFinance NeuroVentures Capital LLC (NeuroVenture Capital) is a venture capital firm founded in 1999 by Mark A. Cochran, Daniel J. O'Connell and Hans von Celsing. The firm is headquartered in Charlottesville, Virginia. | Finance |
Nitrase Therapeutics, Inc.
Nitrase Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nitrase Therapeutics, Inc. develops drugs against newly discovered nitration enzyme. The firm provides disease modifying drugs for multiple additional aging-dependent diseases, such as neurodegenerative disease, heart disease and cancer. The company was founded by Irene Griswold-Prenner and is headquartered in Jackson, WY. | Commercial Services |